Pharvaris NV (PHVS)
28.97
+0.39
(+1.36%)
USD |
NASDAQ |
Apr 20, 16:00
29.01
+0.04
(+0.14%)
Pre-Market: 20:00
Pharvaris EPS Diluted (Quarterly) : -0.8343 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -0.5949 |
| ProQR Therapeutics NV | -0.1008 |
| argenx SE | -- |
| Pharming Group NV | 0.0699 |
| NewAmsterdam Pharma Co. NV | -0.6549 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.40M |
| Total Expenses (Quarterly) | 54.40M |
| Enterprise Value | 1.553B |
| Earnings Yield | -11.63% |
| Normalized Earnings Yield | -11.63 |